nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCC2—ABC-family proteins mediated transport—ABCA4—cleft lip	0.0415	0.0415	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—MSX1—cleft lip	0.041	0.041	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—TGFB3—cleft lip	0.0375	0.0375	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—PAX7—cleft lip	0.0349	0.0349	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—TFAP2A—cleft lip	0.0311	0.0311	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—BHMT2—cleft lip	0.0281	0.0281	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—EPHA3—cleft lip	0.0236	0.0236	CbGpPWpGaD
Lovastatin—HDAC2—Hedgehog signaling events mediated by Gli proteins—PTCH1—cleft lip	0.0234	0.0234	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—SUMO1—cleft lip	0.0228	0.0228	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TGFB3—cleft lip	0.0223	0.0223	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—BMP4—cleft lip	0.0209	0.0209	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—EPHA3—cleft lip	0.0201	0.0201	CbGpPWpGaD
Lovastatin—ABCB1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.0195	0.0195	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—EPHA3—cleft lip	0.0163	0.0163	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—EPHA3—cleft lip	0.0159	0.0159	CbGpPWpGaD
Lovastatin—UGT1A3—Phase II conjugation—MTR—cleft lip	0.0158	0.0158	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGF8—cleft lip	0.0144	0.0144	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—BMP4—cleft lip	0.0139	0.0139	CbGpPWpGaD
Lovastatin—UGT2B7—Phase II conjugation—MTR—cleft lip	0.0134	0.0134	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP63—cleft lip	0.0133	0.0133	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF7—cleft lip	0.0121	0.0121	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IRF6—cleft lip	0.0117	0.0117	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TGFA—cleft lip	0.0111	0.0111	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF8—cleft lip	0.0111	0.0111	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—TGFA—cleft lip	0.011	0.011	CbGpPWpGaD
Lovastatin—UGT1A1—Phase II conjugation—MTR—cleft lip	0.0109	0.0109	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—TGFA—cleft lip	0.00935	0.00935	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—MTR—cleft lip	0.00924	0.00924	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF3—cleft lip	0.00906	0.00906	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF9—cleft lip	0.00884	0.00884	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—SUMO1—cleft lip	0.008	0.008	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—FGF2—cleft lip	0.00793	0.00793	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—MTR—cleft lip	0.00786	0.00786	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGFR2—cleft lip	0.00772	0.00772	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFA—cleft lip	0.0076	0.0076	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF10—cleft lip	0.00745	0.00745	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFA—cleft lip	0.00741	0.00741	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF7—cleft lip	0.00732	0.00732	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGFR1—cleft lip	0.0072	0.0072	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB3—cleft lip	0.00684	0.00684	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGFR3—cleft lip	0.0068	0.0068	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF7—cleft lip	0.00677	0.00677	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF8—cleft lip	0.00675	0.00675	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—MTR—cleft lip	0.00639	0.00639	CbGpPWpGaD
Lovastatin—HDAC2—NOTCH1 Intracellular Domain Regulates Transcription—MYC—cleft lip	0.00634	0.00634	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF8—cleft lip	0.00625	0.00625	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGFR2—cleft lip	0.00598	0.00598	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGFR1—cleft lip	0.00558	0.00558	CbGpPWpGaD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—cleft lip	0.00551	0.00551	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF3—cleft lip	0.0055	0.0055	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—MTR—cleft lip	0.00537	0.00537	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF9—cleft lip	0.00536	0.00536	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGFR3—cleft lip	0.00527	0.00527	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGF2—cleft lip	0.00526	0.00526	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—MYC—cleft lip	0.00514	0.00514	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF3—cleft lip	0.00509	0.00509	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ARHGAP29—cleft lip	0.00505	0.00505	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF9—cleft lip	0.00496	0.00496	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TYMS—cleft lip	0.00491	0.00491	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00476	0.00476	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—MYC—cleft lip	0.00471	0.00471	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—NOS3—cleft lip	0.00465	0.00465	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—cleft lip	0.00455	0.00455	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF10—cleft lip	0.00452	0.00452	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00433	0.00433	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF10—cleft lip	0.00418	0.00418	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—cleft lip	0.00414	0.00414	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—cleft lip	0.0041	0.0041	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF2—cleft lip	0.00407	0.00407	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00407	0.00407	CbGpPWpGaD
Lovastatin—HDAC2—Disease—WNT9B—cleft lip	0.00395	0.00395	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00389	0.00389	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—MTR—cleft lip	0.00388	0.00388	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGFR2—cleft lip	0.00363	0.00363	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ABCA4—cleft lip	0.00352	0.00352	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—MYC—cleft lip	0.00344	0.00344	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGFR1—cleft lip	0.00338	0.00338	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC19A1—cleft lip	0.00338	0.00338	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—MTR—cleft lip	0.00336	0.00336	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGFR2—cleft lip	0.00336	0.00336	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—MYC—cleft lip	0.00323	0.00323	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC19A1—cleft lip	0.00322	0.00322	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGFR3—cleft lip	0.0032	0.0032	CbGpPWpGaD
Lovastatin—HDAC2—Disease—WNT3—cleft lip	0.00314	0.00314	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGFR1—cleft lip	0.00313	0.00313	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—cleft lip	0.00312	0.00312	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—MTR—cleft lip	0.003	0.003	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGFR3—cleft lip	0.00296	0.00296	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TCN2—cleft lip	0.0028	0.0028	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—WNT9B—cleft lip	0.00277	0.00277	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—MTR—cleft lip	0.00276	0.00276	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC19A1—cleft lip	0.00275	0.00275	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—MTR—cleft lip	0.00274	0.00274	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TCN2—cleft lip	0.00267	0.00267	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOG—cleft lip	0.00265	0.00265	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF2—cleft lip	0.00247	0.00247	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ABCA4—cleft lip	0.00247	0.00247	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC19A1—cleft lip	0.00234	0.00234	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF2—cleft lip	0.00229	0.00229	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TCN2—cleft lip	0.00228	0.00228	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—WNT3—cleft lip	0.0022	0.0022	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SPRY2—cleft lip	0.00208	0.00208	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF7—cleft lip	0.00208	0.00208	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC19A1—cleft lip	0.00204	0.00204	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00204	0.00204	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.00198	0.00198	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MTR—cleft lip	0.00194	0.00194	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TCN2—cleft lip	0.00194	0.00194	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF8—cleft lip	0.00192	0.00192	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC19A1—cleft lip	0.0019	0.0019	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTR—cleft lip	0.00185	0.00185	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—MTR—cleft lip	0.00181	0.00181	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC19A1—cleft lip	0.00174	0.00174	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TCN2—cleft lip	0.00169	0.00169	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00165	0.00165	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC19A1—cleft lip	0.0016	0.0016	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MTR—cleft lip	0.00158	0.00158	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TCN2—cleft lip	0.00158	0.00158	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF3—cleft lip	0.00156	0.00156	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF9—cleft lip	0.00152	0.00152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPRY2—cleft lip	0.00145	0.00145	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF7—cleft lip	0.00145	0.00145	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TCN2—cleft lip	0.00144	0.00144	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS3—cleft lip	0.00143	0.00143	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.0014	0.0014	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MTR—cleft lip	0.00134	0.00134	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF8—cleft lip	0.00134	0.00134	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TCN2—cleft lip	0.00133	0.00133	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF10—cleft lip	0.00128	0.00128	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTCH1—cleft lip	0.00121	0.00121	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TYMS—cleft lip	0.00119	0.00119	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MTR—cleft lip	0.00117	0.00117	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC19A1—cleft lip	0.00116	0.00116	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF3—cleft lip	0.00109	0.00109	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MTR—cleft lip	0.00109	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF9—cleft lip	0.00107	0.00107	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MTHFR—cleft lip	0.00104	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR2—cleft lip	0.00103	0.00103	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.00102	0.00102	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC19A1—cleft lip	0.001	0.001	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTR—cleft lip	0.001	0.001	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTHFR—cleft lip	0.000991	0.000991	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TYMS—cleft lip	0.000969	0.000969	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR1—cleft lip	0.00096	0.00096	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TCN2—cleft lip	0.000958	0.000958	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTR—cleft lip	0.000919	0.000919	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR3—cleft lip	0.000907	0.000907	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF10—cleft lip	0.000899	0.000899	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC19A1—cleft lip	0.000894	0.000894	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC19A1—cleft lip	0.000872	0.000872	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MTHFR—cleft lip	0.000846	0.000846	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TCN2—cleft lip	0.00083	0.00083	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TYMS—cleft lip	0.000824	0.000824	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC19A1—cleft lip	0.000822	0.000822	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC19A1—cleft lip	0.000815	0.000815	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TCN2—cleft lip	0.000741	0.000741	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NOS3—cleft lip	0.000724	0.000724	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TCN2—cleft lip	0.000723	0.000723	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR2—cleft lip	0.000721	0.000721	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MTHFR—cleft lip	0.00072	0.00072	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TYMS—cleft lip	0.000717	0.000717	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF2—cleft lip	0.000701	0.000701	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS3—cleft lip	0.000691	0.000691	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TCN2—cleft lip	0.000681	0.000681	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TCN2—cleft lip	0.000675	0.000675	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR1—cleft lip	0.000672	0.000672	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TYMS—cleft lip	0.000669	0.000669	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000667	0.000667	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTR—cleft lip	0.000664	0.000664	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR3—cleft lip	0.000635	0.000635	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MTHFR—cleft lip	0.000627	0.000627	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TYMS—cleft lip	0.000613	0.000613	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NOS3—cleft lip	0.00059	0.00059	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MTHFR—cleft lip	0.000585	0.000585	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTR—cleft lip	0.000575	0.000575	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TYMS—cleft lip	0.000563	0.000563	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000537	0.000537	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MTHFR—cleft lip	0.000536	0.000536	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTR—cleft lip	0.000513	0.000513	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NOS3—cleft lip	0.000502	0.000502	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTR—cleft lip	0.000501	0.000501	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—cleft lip	0.000494	0.000494	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTHFR—cleft lip	0.000492	0.000492	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF2—cleft lip	0.000491	0.000491	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—cleft lip	0.000484	0.000484	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTR—cleft lip	0.000472	0.000472	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTR—cleft lip	0.000468	0.000468	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—cleft lip	0.000458	0.000458	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TCN2—cleft lip	0.000445	0.000445	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—cleft lip	0.000437	0.000437	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—cleft lip	0.000408	0.000408	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TYMS—cleft lip	0.000407	0.000407	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—cleft lip	0.000374	0.000374	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—cleft lip	0.000356	0.000356	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—cleft lip	0.000353	0.000353	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—cleft lip	0.000343	0.000343	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—cleft lip	0.000321	0.000321	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—cleft lip	0.000315	0.000315	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTR—cleft lip	0.000309	0.000309	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—cleft lip	0.000308	0.000308	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—cleft lip	0.000307	0.000307	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—cleft lip	0.000289	0.000289	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—cleft lip	0.000287	0.000287	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—cleft lip	0.000275	0.000275	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—cleft lip	0.000268	0.000268	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—cleft lip	0.000253	0.000253	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—cleft lip	0.000251	0.000251	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—cleft lip	0.000248	0.000248	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—cleft lip	0.000215	0.000215	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—cleft lip	0.000192	0.000192	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—cleft lip	0.000189	0.000189	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—cleft lip	0.000187	0.000187	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—cleft lip	0.000176	0.000176	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—cleft lip	0.000175	0.000175	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—cleft lip	0.000165	0.000165	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—cleft lip	0.000115	0.000115	CbGpPWpGaD
